Bromocriptine suppression of TRH-stimulated prolactin and thyrotrophin release and accompanying inhibition of bromocriptine induced growth hormone release by TRH in normal man.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 113143)

Published in Clin Endocrinol (Oxf) on May 01, 1979

Authors

P M Brown, R Bacchus, L Sachs, P H Sönksen, M Wheeler

Articles by these authors

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (1991) 9.21

Home monitoring of blood-glucose. Method for improving diabetic control. Lancet (1978) 7.12

The cloning of normal "mast" cells in tissue culture. J Cell Physiol (1965) 5.47

Interaction of the carbohydrate-binding protein concanavalin A with normal and transformed cells. Proc Natl Acad Sci U S A (1969) 5.39

Characterization of the simian virus 40-specific RNA in virus-yielding and transformed cells. J Mol Biol (1968) 4.65

The induction of cellular DNA synthesis by simian virus 40 in contact-inhibited and in x-irradiated cells. Proc Natl Acad Sci U S A (1966) 4.64

In vitro transformation of normal cells to tumor cells by carcinogenic hydrocarbons. J Natl Cancer Inst (1965) 4.53

In vitro control of the development of macrophage and granulocyte colonies. Proc Natl Acad Sci U S A (1966) 4.13

Structural difference in sites on the surface membrane of normal and transformed cells. Nature (1969) 3.81

The induction of clones of normal mast cells by a substance from conditioned medium. Exp Cell Res (1966) 3.01

Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature (1978) 2.97

Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet (1991) 2.96

Pupillary signs in diabetic autonomic neuropathy. Br Med J (1978) 2.79

In vitro cell transformation by x-irradiation. Nature (1966) 2.75

Induction of colony formation in vitro by human lymphocytes. Nature (1976) 2.71

On the mechanism of polyoma virus-induced synthesis of cellular DNA. Proc Natl Acad Sci U S A (1965) 2.67

The Brighton resuscitation ambulances: a continuing experiment in prehospital care by ambulance staff. Br Med J (1976) 2.66

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med (1989) 2.57

Growth-hormone and cortisol responses to insulin infusion in patients with diabetes mellitus. Lancet (1972) 2.53

Destruction of mouse and rat embryo cells in tissue culture by lymph node cells from unsensitized rats. J Cell Physiol (1965) 2.44

A comparative study on the metabolism of human insulin and porcine proinsulin in man. Clin Sci Mol Med (1973) 2.33

Specific inhibition by N-acetyl-D-galactosamine of the interaction between soybean agglutinin and animal cell surfaces. Biochim Biophys Acta (1970) 2.33

Changes of carbohydrate tolerance in acromegaly with progress of the disease and in response to treatment. J Clin Endocrinol Metab (1967) 2.27

Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci U S A (1990) 2.25

In vitro induction of granulocyte differentiation in hematopoietic cells from leukemic and non-leukemic patients. Proc Natl Acad Sci U S A (1970) 2.22

Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion. Proc Natl Acad Sci U S A (1979) 2.17

Cervical competence as a continuum: a study of ultrasonographic cervical length and obstetric performance. Am J Obstet Gynecol (1995) 2.10

Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci U S A (2001) 2.10

Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci U S A (1997) 2.05

Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells. Proc Natl Acad Sci U S A (1976) 1.96

Hybridization between SV40 DNA and cellular DNA's. J Mol Biol (1969) 1.92

Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood (1993) 1.90

Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab (1998) 1.89

Cell susceptibility to transformation and cytotoxicity by the carcinogenic hydrocarbon benzo[a]pyrene. Proc Natl Acad Sci U S A (1966) 1.86

Identification and treatment of risk factors for coronary heart disease in general practice: a possible screening model. Br Med J (Clin Res Ed) (1988) 1.85

Treatment of diabetic coma with continuous low-dose infusion of insulin. Br Med J (1974) 1.82

DNA sequence preferences of several AT-selective minor groove binding ligands. Nucleic Acids Res (1995) 1.82

Control of lysozyme induction in the differentiation of myeloid leukemic cells. Cell (1976) 1.79

Reversion of properties in cells transformed by polyoma virus. Nature (1968) 1.79

DNA rearrangement of a homeobox gene in myeloid leukaemic cells. EMBO J (1988) 1.75

Biosynthesis and functions of melanin in Sporothrix schenckii. Infect Immun (2000) 1.68

The continued requirement for inducer for the development of macrophage and granulocyte colonies. J Cell Physiol (1968) 1.67

Receptor mobility and the mechanism of cell-cell binding induced by concanavalin A. Proc Natl Acad Sci U S A (1974) 1.65

An analysis of the mechanism of neoplastic cell transformation by polyoma virus, hydrocarbons, and x-irradiation. Curr Top Dev Biol (1967) 1.64

DIABEDS: a randomized trial of the effects of physician and/or patient education on diabetes patient outcomes. J Chronic Dis (1987) 1.64

Differential toxicity on normal and transformed cells in vitro and inhibition of tumour development in vivo by concanavalin A. Nature (1970) 1.64

Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells. Proc Natl Acad Sci U S A (1977) 1.64

The in vitro induction of an increase in cell multiplication and cellular life span by the water-soluble carcinogen dimethylnitrosamine. Proc Natl Acad Sci U S A (1968) 1.60

The difference in contact inhibition of cell replication between normal cells and cells transformed by different carcinogens. Proc Natl Acad Sci U S A (1966) 1.59

Cholelithiasis: a clinical and dietary survey. Gut (1970) 1.55

Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study. Ann Rheum Dis (2010) 1.53

Why patients were lost from follow-up at an urban diabetic clinic. Br Med J (Clin Res Ed) (1983) 1.51

Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth Differ (1993) 1.50

Ciromosomal control of reversion in transformed cells. Nature (1971) 1.48

Different blocks in the differentiation of myeloid leukemic cells. Proc Natl Acad Sci U S A (1974) 1.47

Mutability of different genetic loci in mammalian cells by metabolically activated carcinogenic polycyclic hydrocarbons. Proc Natl Acad Sci U S A (1976) 1.47

Comparison of a rigid laryngoscope with the ultrathin fibreoptic laryngoscope for tracheal intubation in infants. Can J Anaesth (1994) 1.47

The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin-6. Blood (1988) 1.47

A theory on the mechanism of carcinogenesis by small deoxyribonucleic acid tumour viruses. Nature (1965) 1.45

Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing: a case-control study. Diabet Med (1998) 1.45

Control of the reversion of properties in transformed cells. Nature (1970) 1.44

Growth hormone replacement therapy in adults with growth hormone deficiency improves vascular reactivity. Clin Endocrinol (Oxf) (1999) 1.44

45,X/47,XYY mosaicism: clinical discrepancy between prenatally and postnatally diagnosed cases. Am J Med Genet (1991) 1.43

The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf) (1992) 1.43

Control of normal differentiation of myeloid leukemic cells. VIII. Induction of differentiation to mature granulocytes in mass culture. J Cell Physiol (1975) 1.42

Association of the DVWA and GDF5 polymorphisms with osteoarthritis in UK populations. Ann Rheum Dis (2008) 1.42

Cell susceptibility to transformation by x-irradiation and fixation of the transformed state. Proc Natl Acad Sci U S A (1967) 1.41

Rotational relaxation time of concanavalin A bound to the surface membrane of normal and malignant transformed cells. J Mol Biol (1973) 1.40

Bilateral sudden visual loss due to sphenoid mucocele in Albright's syndrome. Br J Ophthalmol (1995) 1.40

Geographic and social factors are related to increased morbidity and mortality rates in diabetic patients. Diabet Med (2000) 1.40

Time series analysis and control of blood glucose levels in diabetic patients. Comput Methods Programs Biomed (1994) 1.39

Showing neuropathy is related to increased mortality in diabetic patients - a survival analysis using an accelerated failure time model. J Clin Epidemiol (2000) 1.39

Fat replacers: their use in foods and role in diabetes medical nutrition therapy. Diabetes Care (1996) 1.39

Mobility of carbohydrate containing sites on the surface membrane in relation to the control of cell growth. FEBS Lett (1973) 1.39

Regulation of membrane changes, differentiation, and malignancy in carcinogenesis. Harvey Lect (1974) 1.39

[CFS, the condition with the thousands different names. "The tired nomad"--a modern epidemic?]. Lakartidningen (1994) 1.38

Ion metabolism in a Halobacterium. I. Influence of age of culture on intracellular concentrations. J Gen Physiol (1970) 1.38

Quality control of home monitoring of blood glucose concentrations. Br Med J (Clin Res Ed) (1984) 1.38

Mutagenesis and transformation of normal cells by chemical carcinogens. Nature (1976) 1.37

Inhibition of ascites tumor development by concanavalin A. Int J Cancer (1972) 1.36

Control of normal differentiation of myeloid leukemic cells to macrophages and granulocytes. Proc Natl Acad Sci U S A (1973) 1.36

Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: a model for the origin and progression of malignancy. Proc Natl Acad Sci U S A (1980) 1.35

Induction of virus synthesis in polyoma transformed cells by ultraviolet light and mitomycin C. Virology (1970) 1.34

Enzymatic hydroxylation of benzopyrene and its relationship to cytotoxicity. Proc Natl Acad Sci U S A (1969) 1.33

Cell-mediated mutagenesis of mammalian cells with chemical carcinogens. Int J Cancer (1974) 1.32

Arterial wall compliance in diabetes. Diabet Med (1992) 1.32

Genetic dissection of the control of normal differentiation in myeloid leukemic cells. Proc Natl Acad Sci U S A (1977) 1.32

AIDA: an interactive diabetes advisor. Comput Methods Programs Biomed (1994) 1.31

The stimulation of tumor cell growth by a substance produced by normal and tumor cells. J Cell Physiol (1969) 1.30

Photoreactive insulin analogues used to characterise the insulin receptor. Biochem Biophys Res Commun (1980) 1.30

Formation of bone tissue in culture from isolated bone cells. J Cell Biol (1974) 1.30

The activation of virus synthesis in polyoma-transformed cells. Virology (1969) 1.28

Induction of specific changes in the surface membrane of myeloid leukemic cells by steroid hormones. Int J Cancer (1975) 1.28

Receptor mobility and the binding of cells to lectin-coated fibers. J Cell Biol (1975) 1.27

Papovaviridae. Intervirology (1974) 1.26

Regulation of the induction of colonies in vitro by normal human lymphocytes. Proc Natl Acad Sci U S A (1976) 1.24

The effect of hypoglycaemia on visual function: a clinical and electrophysiological study. Clin Sci (Lond) (1985) 1.24

Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. Horm Res (1990) 1.24

The oncogenic potential of an activated Hox-2.4 homeobox gene in mouse fibroblasts. Mol Cell Biol (1991) 1.23